Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
Hepatocellular carcinoma (HCC) is one of the common malignances in the world and has high mortality in part due to development of acquired drug resistance. Therefore, it is urgent to investigate the molecular mechanism of drug resistance in HCC. To explore the underlying mechanism of drug resistance...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875765/ https://www.ncbi.nlm.nih.gov/pubmed/24158561 |
_version_ | 1782297407068831744 |
---|---|
author | Wu, Qiong Wang, Rui Yang, Qingling Hou, Xin Chen, Sulian Hou, Yueyue Chen, Changjie Yang, Yan Miele, Lucio Sarkar, Fazlul H Chen, Yuqing Wang, Zhiwei |
author_facet | Wu, Qiong Wang, Rui Yang, Qingling Hou, Xin Chen, Sulian Hou, Yueyue Chen, Changjie Yang, Yan Miele, Lucio Sarkar, Fazlul H Chen, Yuqing Wang, Zhiwei |
author_sort | Wu, Qiong |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is one of the common malignances in the world and has high mortality in part due to development of acquired drug resistance. Therefore, it is urgent to investigate the molecular mechanism of drug resistance in HCC. To explore the underlying mechanism of drug resistance in HCC, we developed gemcitabine-resistant (GR) HCC cells. We used multiple methods to achieve our goal including RT-PCR, Western blotting analysis, transfection, Wound-healing assay, migration and invasion assay. We observed that gemcitabine-resistant cells acquired epithelial-mesenchymal transition (EMT) phenotype. Moreover, we found that PDGF-D is highly expressed in GR cells. Furthermore, down-regulation of PDGF-D in GR cells led to partial reversal of the EMT phenotype. Our findings demonstrated that targeting PDGF-D could be a novel strategy to overcome gemcitabine resistance in HCC. |
format | Online Article Text |
id | pubmed-3875765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-38757652014-01-07 Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway Wu, Qiong Wang, Rui Yang, Qingling Hou, Xin Chen, Sulian Hou, Yueyue Chen, Changjie Yang, Yan Miele, Lucio Sarkar, Fazlul H Chen, Yuqing Wang, Zhiwei Oncotarget Research Paper Hepatocellular carcinoma (HCC) is one of the common malignances in the world and has high mortality in part due to development of acquired drug resistance. Therefore, it is urgent to investigate the molecular mechanism of drug resistance in HCC. To explore the underlying mechanism of drug resistance in HCC, we developed gemcitabine-resistant (GR) HCC cells. We used multiple methods to achieve our goal including RT-PCR, Western blotting analysis, transfection, Wound-healing assay, migration and invasion assay. We observed that gemcitabine-resistant cells acquired epithelial-mesenchymal transition (EMT) phenotype. Moreover, we found that PDGF-D is highly expressed in GR cells. Furthermore, down-regulation of PDGF-D in GR cells led to partial reversal of the EMT phenotype. Our findings demonstrated that targeting PDGF-D could be a novel strategy to overcome gemcitabine resistance in HCC. Impact Journals LLC 2013-10-07 /pmc/articles/PMC3875765/ /pubmed/24158561 Text en Copyright: © 2013 Wu et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
spellingShingle | Research Paper Wu, Qiong Wang, Rui Yang, Qingling Hou, Xin Chen, Sulian Hou, Yueyue Chen, Changjie Yang, Yan Miele, Lucio Sarkar, Fazlul H Chen, Yuqing Wang, Zhiwei Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title | Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title_full | Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title_fullStr | Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title_full_unstemmed | Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title_short | Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway |
title_sort | chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of pdgf-d pathway |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875765/ https://www.ncbi.nlm.nih.gov/pubmed/24158561 |
work_keys_str_mv | AT wuqiong chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT wangrui chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT yangqingling chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT houxin chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT chensulian chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT houyueyue chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT chenchangjie chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT yangyan chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT mielelucio chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT sarkarfazlulh chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT chenyuqing chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway AT wangzhiwei chemoresistancetogemcitabineinhepatomacellsinducesepithelialmesenchymaltransitionandinvolvesactivationofpdgfdpathway |